Pulmonx Corp
(LUNG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,721 | 70,394 | 83,784 | 95,181 | 102,047 |
| Marketable Securities | 51,081 | 45,973 | 33,555 | 21,537 | 33,571 |
| Receivables | 11,080 | 10,522 | 12,105 | 10,091 | 8,941 |
| Inventories | 16,980 | 17,228 | 16,743 | 16,131 | 15,636 |
| TOTAL | $146,159 | $147,936 | $150,422 | $147,364 | $164,428 |
| Non-Current Assets | |||||
| PPE Net | 2,830 | 4,218 | 4,028 | 4,065 | 4,218 |
| Investments And Advances | 2,300 | 6,815 | 16,970 | 26,716 | 16,888 |
| Intangibles | 2,333 | 2,333 | 2,364 | 2,395 | 2,425 |
| Other Non-Current Assets | 19,005 | 3,282 | 3,997 | 4,476 | 5,154 |
| TOTAL | $26,468 | $16,648 | $27,359 | $37,652 | $28,685 |
| Total Assets | $172,627 | $164,584 | $177,781 | $185,016 | $193,113 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 93 | 5,231 | 2,155 | 91 | 93 |
| Accounts payable and accrued liabilities | 3,181 | 3,125 | 1,497 | 3,189 | 2,377 |
| Accrued Expenses | 11,783 | 10,071 | 16,234 | 13,684 | 13,562 |
| TOTAL | $16,301 | $21,294 | $23,157 | $20,485 | $19,521 |
| Non-Current Liabilities | |||||
| Long Term Debt | 37,110 | 32,002 | 35,089 | 37,154 | 37,147 |
| Deferred Revenues | 107 | 110 | 104 | 85 | 95 |
| Other Non-Current Liabilities | 17,914 | 650 | 1,106 | 1,537 | 2,399 |
| TOTAL | $55,142 | $32,792 | $36,309 | $38,788 | $39,640 |
| Total Liabilities | $71,443 | $54,086 | $59,466 | $59,273 | $59,161 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,153 | 38,816 | 38,537 | 38,308 | 38,028 |
| Common Shares | 39 | 39 | 39 | 38 | 38 |
| Retained earnings | -440,236 | -424,910 | -411,161 | -397,273 | -382,373 |
| Other shareholders' equity | 1,973 | 1,963 | 2,640 | 1,944 | 1,956 |
| TOTAL | $101,184 | $110,498 | $118,315 | $125,743 | $133,952 |
| Total Liabilities And Equity | $172,627 | $164,584 | $177,781 | $185,016 | $193,113 |